With the alarming increase in the prevalence of allergy and immune-related diseases over the past 20 years, especially among children, there is an urgent need to accelerate the development of novel, patient-oriented diagnostic and treatment protocols.
The AllerGen-CAAIF Emerging Clinician-Scientist Research Fellowship addresses the shortage of allergy and clinical immunology expertise in Canada and advances AllerGen’s goal to support Canadian clinical immunologists and allergists in the pursuit of research training and a combined career as a clinician and an academic researcher.
The award provides up to $250,000 for a maximum of two years (an award of $100,000 plus a $25,000 research allowance each year) to a clinician who has completed clinical immunology and allergy sub-specialty training.
The AllerGen-CAAIF Emerging Clinician-Scientist Research Fellowship aims to:
- strengthen the academic capacity of Canadian clinical immunology and allergy sub-specialists;
- increase Canadian capacity for translational clinical immunology and allergy research; and
- facilitate enhanced patient care through excellence in basic and clinical allergy and related immune disease research.
Eligible academic foci include basic and/or clinical research related to allergy, asthma and/or anaphylaxis. The quality of the research or training opportunity and the potential for a combined career as a clinician and researcher are the principal criteria on which applications are judged.
Details regarding the terms and conditions of funding, eligibility, evaluative criteria and the application process are all outlined in the Call for Applications below.
**NEW: Applicants who successfully completed Clinical Immunology and Allergy sub-specialty training or PhD studies in 2015, 2016 or 2017 are eligible to apply. Individuals completing Clinical Immunology and Allergy sub-specialty training or PhD studies in 2018,and beyond are not eligible to apply, due to the conclusion of AllerGen NCE-funding on March 31, 2019.
**NOUVEAU: Les candidats qui ont terminé avec succès la formation de sous-spécialité en immunologie clinique et en allergologie ou les études de doctorat en 2015, 2016 ou 2017, sont admissibles. Les personnes qui terminent la formation de sous-spécialité en immunologie clinique et d’allergie ou les études de doctorat en 2018 et au-delà ne sont pas admissibles à la candidature, en raison de la conclusion du financement AllerGen NCE le 31 mars 2019.
December 1, 2017
For more information, please contact:
Highly Qualified Personnel (HQP) and Events Coordinator
AllerGen NCE Inc.
(905) 525-9140 x 26633